(-0.08%) 5 474.25 points
(-0.11%) 38 776 points
(-0.04%) 19 913 points
(0.22%) $80.51
(1.26%) $2.82
(0.23%) $2 334.40
(-0.16%) $29.35
(-0.20%) $969.00
(0.01%) $0.932
(-0.16%) $10.64
(0.07%) $0.788
(-1.86%) $86.81
Live Chart Being Loaded With Signals
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications...
Stats | |
---|---|
Šios dienos apimtis | 579 235 |
Vidutinė apimtis | 809 477 |
Rinkos kapitalizacija | 551.91M |
EPS | $-0.670 ( Q1 | 2024-05-09 ) |
Kita pelno data | ( $-0.0900 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-2.53 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0110 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-06 | Shendelman Shoshana | Sell | 61 795 | Common Stock |
2024-06-06 | Perfetti Riccardo | Sell | 22 003 | Common Stock |
2024-06-06 | Funtleyder Leslie D. | Sell | 16 980 | Common Stock |
2024-06-06 | Kanter Stacy J. | Buy | 45 000 | Common Stock |
2024-06-06 | Skyler Jay S | Buy | 45 000 | Common Stock |
INSIDER POWER |
---|
26.39 |
Last 97 transactions |
Buy: 10 149 394 | Sell: 4 949 939 |
Tūris Koreliacija
Applied Therapeutics Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
OZEM | 1 |
EQ | 0.934 |
MSAQX | 0.933 |
EVCGX | 0.93 |
FSMSX | 0.93 |
MAMA | 0.925 |
NBBK | 0.925 |
ORGN | 0.924 |
KARRX | 0.92 |
BULIX | 0.919 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
HDL | -0.978 |
BAER | -0.945 |
NWGL | -0.943 |
QREARX | -0.942 |
HTOOW | -0.927 |
PLTN | -0.918 |
GGLS | -0.918 |
BRLSW | -0.916 |
CLMB | -0.915 |
RDZN | -0.909 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Applied Therapeutics Inc Koreliacija - Valiuta/Žaliavos
Applied Therapeutics Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $9.99M |
Bruto pelnas: | $9.64M (96.47 %) |
EPS: | $-1.420 |
FY | 2023 |
Pajamos: | $9.99M |
Bruto pelnas: | $9.64M (96.47 %) |
EPS: | $-1.420 |
FY | 2022 |
Pajamos: | $0 |
Bruto pelnas: | $-441 000 (0.00 %) |
EPS: | $-2.16 |
FY | 2021 |
Pajamos: | $0.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-4.12 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Applied Therapeutics Inc
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.